May 2003
Volume 44, Issue 13
Free
ARVO Annual Meeting Abstract  |   May 2003
Molecular Mechanisms Underlying PRPF31 Genetic Defects in Retinitis Pigmentosa
Author Affiliations & Notes
  • L. Yuan
    Pediatrics, Washington Univ Med School, St Louis, MO, United States
  • N. Havlioglu
    Pediatrics, Washington Univ Med School, St Louis, MO, United States
  • J. Kimi
    Pediatrics, Washington Univ Med School, St Louis, MO, United States
  • E.M. Johnson, Jr
    Molecular Biology and Pharmacology, Washington Univ Med School, St Louis, MO, United States
  • H. Tang
    Molecular Biology and Pharmacology, Washington Univ Med School, St Louis, MO, United States
  • J.Y. Wu
    Molecular Biology and Pharmacology, Washington Univ Med School, St Louis, MO, United States
  • Footnotes
    Commercial Relationships  L. Yuan, None; N. Havlioglu, None; J. Kimi, None; E.M. Johnson, Jr, None; H. Tang, None; J.Y. Wu, None.
  • Footnotes
    Support  NIH Grant AG17518
Investigative Ophthalmology & Visual Science May 2003, Vol.44, 2839. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      L. Yuan, N. Havlioglu, J. Kimi, E.M. Johnson, Jr, H. Tang, J.Y. Wu; Molecular Mechanisms Underlying PRPF31 Genetic Defects in Retinitis Pigmentosa . Invest. Ophthalmol. Vis. Sci. 2003;44(13):2839.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Abstract: : Purpose: The mutations in human PRPF31 gene have been identified in patients with autosomal dominant retinitis pigmentosa(adRP). This experiment is to investigate the molecular mechanisms by which such mutations cause retinal degeneration. Methods:.We examined effects of wild-type and mutant PRPF31 proteins in a primary retinal neuronal culture system. The cells are plated on the the coverslips and incubated either with the culture medium or the medium containing BAX, a apoptotic inhibitor, for different time points. After transfection in wild-type or mutant PRPF31 genes to the primary retinal cells, the cell death pattern has been followed by TUNEL staining. Results: Following the expression of the mutant PRPF31 proteins in retinal neurons, the viability of retinal neurons was significant decreased. The cells expressing mutant PRPF31 showed nuclear morphology characteristic of apoptosis. The cell death induced by mutant PRPF31 was reduced by treatment with a caspase inhibitor. Conclusions: These experiments reveal that mutant PRPF31 proteins induce retinal neuronal death via caspase-mediated pathway. These results support a gain-of-function toxicity of mutant PRPF31 proteins in retinal neurons, suggesting potential therapeutic intervention by removing the mutant proteins instead of simply providing wild-type PRPF31 protein.

Keywords: retinal degenerations: hereditary • cell death/apoptosis • photoreceptors 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×